Axxcess Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,435
| Closed | -$226K | – | 953 |
|
|
2024
Q2 | $226K | Hold |
2,435
| – | – | 0.01% | 750 |
|
|
2024
Q1 | $231K | Hold |
2,435
| – | – | 0.01% | 757 |
|
|
2023
Q4 | $217K | Buy |
+2,435
| New | +$217K | 0.01% | 752 |
|
|
2022
Q4 | – | Sell |
-7,585
| Closed | -$602K | – | 691 |
|
|
2022
Q3 | $602K | Sell |
7,585
-750
| -9% | -$59.5K | 0.06% | 278 |
|
|
2022
Q2 | $619K | Sell |
8,335
-3,100
| -27% | -$230K | 0.06% | 258 |
|
|
2022
Q1 | $777K | Buy |
+11,435
| New | +$777K | 0.06% | 264 |
|